Search research articles
Contact Us
Filters
Showing results (691-700 of 701) with videos related to
Page
of 71
Sort By:
Gynecologic Oncology Reports
|
April 18, 2022
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
Elizabeth H Stover, Niya Xiong, Andrea P Myers, et al.
Journal of the American College of Radiology : JACR
|
November 5, 2013
ACR appropriateness criteria staging and follow-up of ovarian cancer
Donald G Mitchell, Marcia C Javitt, Phyllis Glanc, et al.
JCO Precision Oncology
|
April 10, 2025
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer
Panagiotis A Konstantinopoulos, Mingyang Cai, Elizabeth K Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 21, 2019
Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes
Yassemine Khawajkie, Nawel Mechtouf, Ngoc Minh Phuong Nguyen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2020
Correction: Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes
Yassemine Khawajkie, Nawel Mechtouf, Ngoc Minh Phuong Nguyen, et al.
Science Signaling
|
August 24, 2017
A systems approach for discovering linoleic acid derivatives that potentially mediate pain and itch
Christopher E Ramsden, Anthony F Domenichiello, Zhi-Xin Yuan, et al.
Diabetes Technology & Therapeutics
|
March 9, 2022
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial
Ron Brazg, Satish K Garg, Anuj Bhargava, et al.
Cancer Discovery
|
September 15, 2018
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
Sarah J Hill, Brennan Decker, Emma A Roberts, et al.
JNCI Cancer Spectrum
|
June 14, 2022
Advancing Research on Medical Image Perception by Strengthening Multidisciplinary Collaboration
Melissa Treviño, George Birdsong, Ann Carrigan, et al.
Cancer Research
|
November 7, 2020
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer
Changxin Wan, Matthew P Keany, Han Dong, et al.
Page
of 71
Search research articles
Search
Showing results (691-700 of 701) with videos related to
Sort By:
Page
of 71
Gynecologic Oncology Reports
|
April 18, 2022
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
Elizabeth H Stover, Niya Xiong, Andrea P Myers, et al.
Journal of the American College of Radiology : JACR
|
November 5, 2013
ACR appropriateness criteria staging and follow-up of ovarian cancer
Donald G Mitchell, Marcia C Javitt, Phyllis Glanc, et al.
JCO Precision Oncology
|
April 10, 2025
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer
Panagiotis A Konstantinopoulos, Mingyang Cai, Elizabeth K Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 21, 2019
Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes
Yassemine Khawajkie, Nawel Mechtouf, Ngoc Minh Phuong Nguyen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2020
Correction: Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes
Yassemine Khawajkie, Nawel Mechtouf, Ngoc Minh Phuong Nguyen, et al.
Science Signaling
|
August 24, 2017
A systems approach for discovering linoleic acid derivatives that potentially mediate pain and itch
Christopher E Ramsden, Anthony F Domenichiello, Zhi-Xin Yuan, et al.
Diabetes Technology & Therapeutics
|
March 9, 2022
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial
Ron Brazg, Satish K Garg, Anuj Bhargava, et al.
Cancer Discovery
|
September 15, 2018
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
Sarah J Hill, Brennan Decker, Emma A Roberts, et al.
JNCI Cancer Spectrum
|
June 14, 2022
Advancing Research on Medical Image Perception by Strengthening Multidisciplinary Collaboration
Melissa Treviño, George Birdsong, Ann Carrigan, et al.
Cancer Research
|
November 7, 2020
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer
Changxin Wan, Matthew P Keany, Han Dong, et al.
Page
of 71